2 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 1 | 1 | Terminated 1 |
Follow Turcot syndrome: new trials by email Literature Review of Turcot syndrome trials Research Report on Turcot syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pilot Study of Nivolumab in Pediatric Patients With Hypermutant Cancers Nivolumab - Refractory or Recurrent Hypermutated Malignancies, Biallelic Mismatch Repair Deficiency (bMMRD) Positive Patients | Phase 1 / Phase 2 | Terminated | The Hospital for Sick Children | 11 | 2017-05-15 | 2026-11-05 |
| Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004 Avelumab, Ad-CEA vaccine, Bevacizumab - Colorectal Tumors, Colorectal Neoplasms | Phase 2 | Terminated | National Cancer Institute (NCI) | 30 | 2017-04-05 | 2021-12-20 |
Colonic Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Intestinal Diseases (1) · Intestinal Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1) · Rectal Diseases (1)
Bevacizumab (1) · Capecitabine (1) · Fluorouracil (1) · Leucovorin (1) · Nivolumab (1) · Oxaliplatin (1) · avelumab (1)
National Cancer Institute (NCI) (1) · The Hospital for Sick Children (1)
United States (2) · Australia (1) · Canada (1) · France (1) · Israel (1)
Daniel A Morgenstern, MB BChir PhD (1) · Julius Y Strauss, M.D. (1)